Tiziana life sciences announces purchase of common shares by executive chairman

New york, june 09, 2022 (globe newswire) -- tiziana life sciences ltd.(nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that panetta partners limited, an entity in which gabriele cerrone, the executive chairman, has a beneficial interest, purchased 18,000 common shares at $0.80 per share.
TLSA Ratings Summary
TLSA Quant Ranking